ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,948.20
0.00%
S&P ASX All Technology
3,629.80
0.00%
Brent Oil
69.995
-0.34%
US Dollar vs AUD
1.59084
0.00%
Bitcoin
81,041.16
-5.94%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. AcelRX Pharmaceuticals Inc (ACRX) Share Price

AcelRX Pharmaceuticals Inc

AcelRX Pharmaceuticals Inc (ACRX)

NASDAQ
0.86
0.00
(0.00%)
Closed 10 March 7:00AM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.86
Bid
0.861
Offer
0.89
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
14.579M
Previous Close
0.86
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
16,952,000
Dividend Yield
-
PE Ratio
-0.79
Earnings Per Share (EPS)
-1.09
Revenue
651k
Net Profit
-18.4M

About AcelRX Pharmaceuticals Inc

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-... AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
talphera.com
Headquarters
Wilmington, Delaware, USA
Founded
-

Ask ADVFN Intelligence (AI)

ACRX Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
25 June 2024
ACRX (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
25 June 2024
ACRX (0.00%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
30 April 2024
ACRX (0.00%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
30 April 2024
ACRX (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
20 April 2024
ACRX (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
22 March 2024
ACRX (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
16 March 2024
ACRX (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
13 March 2024
ACRX (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
10 January 2024
ACRX (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ACRX - Frequently Asked Questions (FAQ)

What is the current AcelRX Pharmaceuticals share price?
The current share price of AcelRX Pharmaceuticals is US$ 0.86
How many AcelRX Pharmaceuticals shares are in issue?
AcelRX Pharmaceuticals has 16,952,000 shares in issue
What is the market cap of AcelRX Pharmaceuticals?
The market capitalisation of AcelRX Pharmaceuticals is USD 14.58M
What is the 1 year trading range for AcelRX Pharmaceuticals share price?
AcelRX Pharmaceuticals has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of AcelRX Pharmaceuticals?
The price to earnings ratio of AcelRX Pharmaceuticals is -0.79
What is the cash to sales ratio of AcelRX Pharmaceuticals?
The cash to sales ratio of AcelRX Pharmaceuticals is 22.4
What is the reporting currency for AcelRX Pharmaceuticals?
AcelRX Pharmaceuticals reports financial results in USD
What is the latest annual turnover for AcelRX Pharmaceuticals?
The latest annual turnover of AcelRX Pharmaceuticals is USD 651k
What is the latest annual profit for AcelRX Pharmaceuticals?
The latest annual profit of AcelRX Pharmaceuticals is USD -18.4M
What is the registered address of AcelRX Pharmaceuticals?
The registered address for AcelRX Pharmaceuticals is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the AcelRX Pharmaceuticals website address?
The website address for AcelRX Pharmaceuticals is talphera.com
Which industry sector does AcelRX Pharmaceuticals operate in?
AcelRX Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ABLVAble View Global Inc
US$ 1.73
(137.18%)
5.14M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
482.05M
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
622.67M
DWTXDogwood Therapeutics Inc
US$ 6.63
(49.66%)
25.92M
KZIAKazia Therapeutics Ltd
US$ 1.1899
(40.80%)
4.5M
ALBTAvalon GloboCare Corporation
US$ 6.96
(-36.15%)
577.55k
SCNXScienture Holdings Inc
US$ 1.55
(-35.68%)
1.59M
ACXPAcurx Pharmaceuticals Inc
US$ 0.4572
(-29.88%)
1.18M
RETOReTo Eco Solutions Inc
US$ 5.42
(-27.73%)
108.27k
OCTOEightco Holdings Inc
US$ 1.08
(-27.03%)
336.99k
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
618.03M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
476.73M
NVDANVIDIA Corporation
US$ 112.69
(1.92%)
333.91M
ICONIcon Energy Corporation
US$ 0.169898
(17.17%)
140.23M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10.675
(-0.70%)
140.05M

Discussion

View Full Feed
Genz2 Genz2 3 minutes ago
https://eladelantado.com/news/now-official-toyota-recall-engine-issue/

Are you sure you want to short Tesla?? Why not invest in a Tesla Cybertruck or Tesla car rather than an ICE Toyota or any other ICE vehicle that has potential engine problems like this!! Tesla has FSD too!!! Ha
TSLA
stockdoc2 stockdoc2 4 minutes ago
Stovks going back up..Good sign!
CFSU
stockdoc2 stockdoc2 4 minutes ago
Stovks going back up..Good sign!
CFSU
12yearplan 12yearplan 5 minutes ago
Yeah Arizona, listening now and they just announced Mark Carney with over 85% vote support!.
bananarama bananarama 5 minutes ago
Excellent post, Rayo. Thanks a million! GO KBLB! ;-)
KBLB
OMOLIVES OMOLIVES 6 minutes ago
? Tell that to the creditors...lol. Holy shite'
Large Green Large Green 7 minutes ago
Here you go Exostatic.

FDIC DOCUMENT CONCERNING THE WaMu P & A

PLEASE LOOK UP MEANING of Initial Payment

WaMu Purchase Assumption Agreement

WaMu Purchase Assumption Agreement-SOME NEED TO CONCENTRATE ON THE MEANING OF INITIAL PAYMENT
COOP
janice shell janice shell 8 minutes ago
Here's something for you think about, conix. Seems being transgender is a spectrum, not an either/or thing...

https://www.scientificamerican.com/article/sex-redefined-the-idea-of-2-sexes-is-overly-simplistic1/

It's a real eye-opener!
Golden Cross Golden Cross 8 minutes ago
50 - 100% potential here next week
ALLR
gitreal gitreal 9 minutes ago
we are on the brink

Yes, on the brink of...........several billion shares being dumped on investors' heads. The company itself disclosed the amount of convertible debt it took on. Jared gets cash, the lender gets discounted shares, investors get several billion shares of dilution.
NBRI
Golden Cross Golden Cross 9 minutes ago
50 - 100% potential here next week
HOTH
lalaland lalaland 10 minutes ago
Where did you get this info ???
BRLL
midas716 midas716 12 minutes ago
So, let's put this post into perspective.
Boom just hit the bottom on my cryptos and portfollio is green on a Friday...im sorry what were you saying....Like I said...this is not my only investment and I am diversifying....I will be here for a while until I see the news ......So get use to it.
GCAN
Top Penny Top Penny 12 minutes ago
No dilution in awhile, good sign.
PSRU
arizona1 arizona1 13 minutes ago
Uh oh, "the Jews" are at it again, pesky aren't they?

There's something seriously wrong about you. I hope you didn't breed and raise a family of little brooklyns. But maybe the 13 after your name means you have 13 children like all good Hasidic Jews have.

Israel cut e
bobstruths bobstruths 15 minutes ago
I've been thinking how FnF have been treated by the Government leading up to the Conservatorships and then years following, In the months leading up to the Conservatorships FnF did not meet any of the 12 HERA critearia leading to Conservatorship. Henry Paulson's comment that “the last sound they w
FNMA
janice shell janice shell 15 minutes ago
Yes, I saw that. The Dynasty.

But Junior is pretty pathetic. As is Eric. But what about Jared and Ivanka? During Trump's first term, they seriously discussed which of them should be president first.

It'd be funny if they all ran against each other in the primary.
Golden Cross Golden Cross 16 minutes ago
$HOTH $ALLR Top_NASDAQ_Plays_Next_Week_With_50-100%_Potential
ALLR HOTH
ShootingBlanks420 ShootingBlanks420 16 minutes ago
Damn, you are a different kind of evil. ooof
SRMX
Slojab Slojab 16 minutes ago
The correlation speaks for itself. The least educated states from lowest to highest. States that voted for Trump are in red.

West Virginia 1
Mississippi 2
Louisiana 3
Arkansas 4
Alabama 5
Oklahoma 6
Kentucky
Golden Cross Golden Cross 16 minutes ago
$HOTH $ALLR Top_NASDAQ_Plays_Next_Week_With_50-100%_Potential
ALLR HOTH
12yearplan 12yearplan 17 minutes ago
Waiting to see that substance.
HRAL
netmoney1999 netmoney1999 18 minutes ago
Management
AGSS

Your Recent History

NASDAQ
ACRX
AcelRX Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads